Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BMY compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
PFE
Pfizer Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BMY
Bristol Myers Squibb Co
vs
PFE
Pfizer Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BMY, solid
PFE, dashed
BMY
Bristol Myers Squibb Co
Change
62.63
▲
+0.25%
Mkt cap
$127.7B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
PFE
Pfizer Inc
Change
30.40
▼
−0.41%
Regular session
Nov 2 '26
Mkt cap
$174.0B
Revenue
$15.0B
Q2 FY26
Revenue
$62.6B
FY25
vs
Compare
Regular session
Nov 2 '26
BMY
Bristol Myers Squibb Co
vs
PFE
Pfizer Inc
62.63
▲
+0.25%
Price
30.40
▼
−0.41%
$127.7B
Mkt cap
$174.0B
Q3 FY26
$13.1B
Revenue
$15.0B
Q2 FY26
FY25
$48.2B
Revenue
$62.6B
FY25
Change
Change
BMY
62.63
▲
+0.25%
vs
PFE
30.40
▼
−0.41%
Regular session
Nov 2 '26